Startups
The Emblok Embolic Protection System ("Emblok EPS") is a sterile, single use system designed to capture and remove debris dislodged during transcatheter aortic valve replacement (TAVR) procedures from entering cerebral, abdominal and distal vasculature.
Overview
Location
United States, Michigan, Grand Rapids
Employees
11-50
Founded date
2012
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 11, 2017 | Innovative Cardiovascular Solutions Raises $5.0M in Series B Financing | Innovative Cardiovascular Solutions (ICS), a Kalamazoo, MI-based clinical stage company, completed a $5M Series B funding. The proceeds will be used for device development and initiation of a 510(k) clinical study in the U.S. Led by R. Kevi... |
| Innovative Cardiovascular Solutions | “Emblok 360° is designed for Whole Body Embolic Protection during left heart procedures Emblok 360° is designed for Whole Body Embolic Protection during left heart procedures Protects BrainEmblok’s whole body protection system blocks and ca... |
Reviews 0
FAQ about Emblok
When was Emblok founded?
Emblok was founded in 2012.
What has the press written about Emblok?
Parsers VC has collected 3 articles mentioning Emblok, among them “Innovative Cardiovascular Solutions Raises $5.0M in Series B Financing” (Jul 11, 2017) and “Innovative Cardiovascular Solutions”.
Is Emblok still active?
Yes, Emblok is active; its latest activity on Parsers VC dates from Dec 20, 2018.